Annual Results Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
2,541.18
2,447.15
2,312.86
2,043.38
1,856.32
1,825.55
1,726.84
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
2,541.18
2,447.15
2,312.86
2,043.38
1,856.32
1,825.55
1,726.84
Raw Material Cost
1,496.33
1,408.66
1,238.08
1,091.10
978.69
933.44
869.30
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
525.08
511.81
490.73
481.42
423.91
436.70
407.61
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
77.40
68.87
69.99
56.83
40.72
42.11
40.76
Selling and Distribution Expenses
499.28
453.12
546.24
424.59
343.20
353.26
345.68
Other Expenses
-48.79
-47.03
-44.09
-42.13
-36.43
-37.51
-35.27
Total Expenditure (Excl Depreciation)
2,110.19
1,972.12
1,904.18
1,632.60
1,422.23
1,390.41
1,310.61
Operating Profit (PBDIT) excl Other Income
431
475
408.7
410.79999999999995
434.09999999999997
435.09999999999997
416.2
Other Income
6.83
-11.74
-0.80
-7.31
-26.18
-16.38
-2.35
Operating Profit (PBDIT)
598.68
617.46
547.85
557.73
529.34
524.04
467.18
Interest
77.40
68.87
69.99
56.83
40.72
42.11
40.76
Exceptional Items
33.39
-39.13
-98.15
-157.50
27.63
58.49
50.17
Gross Profit (PBDT)
1,044.85
1,038.49
1,074.77
952.28
877.62
892.11
857.54
Depreciation
160.86
154.17
153.65
154.25
121.43
105.28
91.71
Profit Before Tax
393.81
355.29
226.06
189.16
394.82
435.14
384.87
Tax
84.98
72.78
71.60
34.10
90.16
99.82
3.14
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
305.03
280.95
152.85
152.62
306.11
336.10
380.96
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
305.03
280.95
152.85
152.62
306.11
336.10
380.96
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
3.79
2.35
1.61
2.44
-0.73
-0.78
0.78
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
308.83
283.30
154.46
155.06
305.39
335.32
381.74
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.0
0.0
0.0
0.0
0.0
0.0
0.0
Reserves
1,927.81
1,844.46
1,724.19
1,774.88
1,811.07
1,561.87
1,598.04
Earnings per share (EPS)
1.37
1.26
0.69
0.68
1.31
1.41
1.57
Diluted Earnings per share
1.37
1.26
0.69
0.68
1.31
1.41
1.57
Operating Profit Margin (Excl OI)
16.96%
19.41%
17.08%
20.1%
23.38%
23.84%
21.88%
Gross Profit Margin
21.83%
20.82%
16.42%
16.81%
27.81%
29.6%
27.6%
PAT Margin
12.0%
11.48%
6.61%
7.47%
16.49%
18.41%
22.06%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 3.84% vs 5.81% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is 9.00% vs 83.37% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is -5.93% vs 14.69% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 12.34% vs -1.57% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
Compare Annual Results Of Hikma Pharmaceuticals Plc With
Figures in Million
Consolidate Annual Results
Change(GBP)
Change(%)
Net Sales
2,541.18
32,667.00
-30,125.82
-92.22%
Other Operating Income
0.00
0.00
0.00
Total Operating income
2,541.18
32,667.00
-30,125.82
-92.22%
Raw Material Cost
1,496.33
9,323.00
-7,826.67
-83.95%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
525.08
8,398.00
-7,872.92
-93.75%
Power Cost
0
0
0.00
Manufacturing Expenses
77.40
667.00
-589.60
-88.40%
Selling and Distribution Expenses
499.28
8,926.00
-8,426.72
-94.41%
Other Expenses
-48.79
-286.50
237.71
82.97%
Total Expenditure (Excl Depreciation)
2,110.19
24,449.00
-22,338.81
-91.37%
Operating Profit (PBDIT) excl Other Income
430.99
8,218.00
-7,787.01
-94.76%
Other Income
6.83
1,450.00
-1,443.17
-99.53%
Operating Profit (PBDIT)
598.68
11,982.00
-11,383.32
-95.00%
Interest
77.40
667.00
-589.60
-88.40%
Exceptional Items
33.39
-1,601.00
1,634.39
102.09%
Gross Profit (PBDT)
1,044.85
23,344.00
-22,299.15
-95.52%
Depreciation
160.86
2,314.00
-2,153.14
-93.05%
Profit Before Tax
393.81
7,400.00
-7,006.19
-94.68%
Tax
84.98
1,112.00
-1,027.02
-92.36%
Provisions and contingencies
0
0
0.00
Profit After Tax
305.03
5,716.00
-5,410.97
-94.66%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
305.03
5,716.00
-5,410.97
-94.66%
Share in Profit of Associates
0
0
0.00
Minority Interest
3.79
573.00
-569.21
-99.34%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
308.83
6,289.00
-5,980.17
-95.09%
Equity Capital
0
0
0.00
Face Value
0.00
0.31
0.00
Reserves
1,927.81
16,377.00
-14,449.19
-88.23%
Earnings per share (EPS)
1.37
1.39
-0.02
-1.44%
Diluted Earnings per share
1.37
1.39
-0.02
-1.44%
Operating Profit Margin (Excl OI)
16.96%
25.16%
0.00
-8.20%
Gross Profit Margin
21.83%
29.74%
0.00
-7.91%
PAT Margin
12.00%
17.50%
0.00
-5.50%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 254.12 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 3.84% vs 5.81% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 30.88 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 9.00% vs 83.37% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 59.19 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -5.93% vs 14.69% in Dec 2024
Annual - Interest
Interest 7.74 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 12.34% vs -1.57% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 16.96%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
